PATRICIA POLENO: Open Payments
NPI 1841485240 · ALLEN PARK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 76 payments from 17 companies in 2025. Trend: 2023 $1,433 · 2024 $1,033 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 7 | $333 |
| Merck Sharp & Dohme LLC | 12 | $270 |
| SCPHARMACEUTICALS INC. | 9 | $187 |
| E.R. Squibb & Sons, L.L.C. | 10 | $181 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $169 |
| PFIZER INC. | 10 | $160 |
| Kestra Medical Technology Services, Inc. | 4 | $101 |
| Novo Nordisk Inc | 3 | $74 |
| BridgeBio Pharma, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
Products named: AMVUTTRA, VERQUVO, FUROSCIX, JARDIANCE, CAMZYOS, VYNDAQEL, Assure WCD, Wegovy.
Industry payments across MI — which companies pay providers there.
